Kymera Therapeutics

KYMR | NASDAQ | 0 Obserwujący

$44.48

-1.61%

-$0.73

Obserwuj

Overview Metrics Financials

Fair Price

$93.20

Overvalued by 12.5%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

Profile

Kymera Therapeutics is a U.S.-based biotechnology company that specializes in the development of therapeutics aimed at protein modulation using advanced protein degradation technologies. The company uses an innovative approach to treating diseases by focusing on selectively degrading faulty proteins in the body rather than blocking them. Kymera Therapeutics focuses on developing drugs for the treatment of oncology, immunology, and rare diseases, with its technology holding the potential to significantly change the way many serious health issues are treated.

Feed

There are no posts to show right now.

Kymera Therapeutics

Fair Price

Profile

Feed

Zaloguj się do Bulios

Utwórz profil Bulios

Dlaczego Bulios?